Lymphopenia News and Research

RSS
Lymphopenia is a condition in which there is a lower-than-normal number of lymphocytes (a type of white blood cell) in the blood. Also called lymphocytic leukopenia and lymphocytopenia.
Crizotinib may be effective treatment option for NSCLC subtype

Crizotinib may be effective treatment option for NSCLC subtype

Specialist referral unearths wide spectrum of adult primary immune deficiencies

Specialist referral unearths wide spectrum of adult primary immune deficiencies

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Combination therapy does not change safety and efficacy relationship of TORISEL for advanced RCC

Pfizer fails to meet primary endpoint in TORISEL Phase 3 study for advanced RCC

Pfizer fails to meet primary endpoint in TORISEL Phase 3 study for advanced RCC

Researchers discover novel genetic mechanism of idiopathic CD4 lymphopenia

Researchers discover novel genetic mechanism of idiopathic CD4 lymphopenia

Bristol-Myers Squibb announces results from daclatasvir plus asunaprevir Phase II HCV study

Bristol-Myers Squibb announces results from daclatasvir plus asunaprevir Phase II HCV study

ONO-4641 reduces number of lesions in people with MS

ONO-4641 reduces number of lesions in people with MS

FTY720 improves locomotor recovery in mice with SCI

FTY720 improves locomotor recovery in mice with SCI

Enrollment complete in Onyx Phase 3 ASPIRE trial for relapsed multiple myeloma

Enrollment complete in Onyx Phase 3 ASPIRE trial for relapsed multiple myeloma

Epigenetic mechanisms maintain tolerance in T cells specific for self antigens

Epigenetic mechanisms maintain tolerance in T cells specific for self antigens

Health Alliance, Bayer sign outcomes-based contract to support MS patients

Health Alliance, Bayer sign outcomes-based contract to support MS patients

New 2-DG-ABT combination cancer therapy triggers apoptosis

New 2-DG-ABT combination cancer therapy triggers apoptosis

Interim data from Cytheris CYT107 Phase I/IIa combination study on HCV

Interim data from Cytheris CYT107 Phase I/IIa combination study on HCV

Rheumavax safe and feasible in treating RA

Rheumavax safe and feasible in treating RA

Takeda receives FDA approval for VELCADE sNDA to treat MM

Takeda receives FDA approval for VELCADE sNDA to treat MM

YM BioSciences announces results of nimotuzumab Phase II study on DIPG

YM BioSciences announces results of nimotuzumab Phase II study on DIPG

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints

Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Celgene's ISTODAX sNDA granted FDA Priority Review classification for progressive/relapsed PTCL

Celgene's ISTODAX sNDA granted FDA Priority Review classification for progressive/relapsed PTCL